Eisen, Howard
( Thomas Jefferson University
, Philadelphia
, Pennsylvania
, United States
)
Pagidipati, Neha
( DCRI
, Durham
, North Carolina
, United States
)
Kohut, Andrew
( Penn Medicine
, Philadelphia
, Pennsylvania
, United States
)
Author Disclosures:
Howard Eisen:DO NOT have relevant financial relationships
| Neha Pagidipati:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Alnylam:Active (exists now)
; Consultant:Esperion:Active (exists now)
; Consultant:Eli Lilly:Active (exists now)
; Consultant:Corsera:Active (exists now)
; Consultant:Corcept:Active (exists now)
; Consultant:Boehringer Ingelheim:Active (exists now)
; Consultant:Bayer:Active (exists now)
; Consultant:Amgen:Active (exists now)
; Research Funding (PI or named investigator):Merck:Active (exists now)
; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now)
; Research Funding (PI or named investigator):Novartis:Active (exists now)
; Research Funding (PI or named investigator):Eli Lilly:Active (exists now)
; Research Funding (PI or named investigator):Boehringer Ingelheim:Active (exists now)
; Research Funding (PI or named investigator):Bayer:Active (exists now)
; Research Funding (PI or named investigator):Amgen:Active (exists now)
| Andrew Kohut:No Answer